Catherine A. Sohn insider trades: Maze Therapeutics (MAZE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Catherine reports to the SEC
and 1 more company
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | MAZE | ↓ Sell | 29,413 | $39.07 | $1.1M | Direct | Jan 8, 2026 (1d) |
| Jan 5, 2026 | ALT | ↑ Buy | 500 | $4.24 | $2K | Direct | Jan 5, 2026 (0d) |
| Mar 17, 2025 | ALT | ↑ Buy | 1,000 | $5.78 | $6K | Direct | Mar 18, 2025 (1d) |
| Aug 14, 2023 | JAZZ | ↓ Sell | 1,241 | $138.16 | $171K | Direct | Aug 15, 2023 (1d) |
| Aug 8, 2022 | JAZZ | ↓ Sell | 1,089 | $152.32 | $166K | Direct | Aug 9, 2022 (1d) |
| Aug 6, 2021 | JAZZ | ↓ Sell | 1,306 | $147.96 | $193K | Direct | Aug 10, 2021 (4d) |
| Nov 4, 2020 | JAZZ | ↓ Sell | 12,500 | $153.44 | $1.9M | Direct | Nov 6, 2020 (2d) |
| Aug 7, 2020 | JAZZ | ↓ Sell | 931 | $125.87 | $117K | Direct | Aug 10, 2020 (3d) |
| Jan 17, 2020 | AXLA | ↑ Buy | 1,000 | $4.87 | $5K | Direct | Jan 21, 2020 (4d) |
| Aug 9, 2019 | JAZZ | ↓ Sell | 726 | $135.65 | $98K | Direct | Aug 12, 2019 (3d) |
| Jan 10, 2019 | LNDC | ↑ Buy | 1,000 | $11.23 | $11K | Direct | Jan 11, 2019 (1d) |
| Aug 10, 2018 | JAZZ | ↓ Sell | 660 | $176.61 | $117K | Direct | Aug 13, 2018 (3d) |
| Jul 20, 2018 | RUBY | ↑ Buy | 2,500 | $23.00 | $58K | Direct | Jul 23, 2018 (3d) |
| Aug 11, 2017 | JAZZ | ↓ Sell | 662 | $142.37 | $94K | Direct | Aug 14, 2017 (3d) |
| Aug 15, 2016 | JAZZ | ↓ Sell | 633 | $136.45 | $86K | Direct | Aug 17, 2016 (2d) |
| Aug 11, 2015 | JAZZ | ↓ Sell | 1,455 | $179.02 | $260K | Direct | Aug 11, 2015 (0d) |
| Aug 12, 2014 | JAZZ | ↓ Sell | 1,731 | $133.15 | $230K | Direct | Aug 14, 2014 (2d) |
| Aug 14, 2013 | JAZZ | ↓ Sell | 640 | $81.02 | $52K | Direct | Aug 14, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MAZE insiders
Open-market trades in the last 12 months
About Catherine A. Sohn's insider trades
Catherine A. Sohn is an insider at Maze Therapeutics (MAZE). Since Aug 14, 2013, Catherine has reported 5 open-market purchases worth $82K and 13 sales worth $4.7M on SEC Form 4. In the last 12 months: 1 buy ($2K) and 1 sale ($1.1M).
Their filings also include grants and awards (38 filings), option exercises (18 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAZE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.